Bessemer Group
OLMA icon

Bessemer Group’s Olema Pharmaceuticals OLMA Stock Holding History

Bessemer Group’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-64
Closed – – 1987
2022
Q1 		$0 Hold
64
– – ﹤0.01% 1920
2021
Q4 		$1K Hold
64
– – ﹤0.01% 1818
2021
Q3 		$2K Hold
64
– – ﹤0.01% 1601
2021
Q2 		$2K Hold
64
– – ﹤0.01% 1521
2021
Q1 		$2K Buy
+64
New +$2.74K ﹤0.01% 1458

Other funds holding OLMA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bessemer Group's OLMA Position: Q2 2022 in Review

Bessemer Group sold out of Olema Pharmaceuticals (OLMA) in Q2 2022, closing a stake of 64 shares.

Bessemer Group first reported a position in OLMA in Q1 2021 and held it in 5 quarters. The position peaked at $2K in Q3 2021. 76 funds tracked by Wall St. Rank hold OLMA as of Q2 2022.

  • Bessemer Group reported no remaining Olema Pharmaceuticals position as of Q2 2022 after selling out during the quarter.
  • Bessemer Group sold 64 Olema Pharmaceuticals shares in Q2 2022.
  • Bessemer Group first reported a position in Olema Pharmaceuticals in Q1 2021 and held it in 5 quarters.
  • Bessemer Group's Olema Pharmaceuticals position peaked at $2K in Q3 2021.
  • 76 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2022.

Based on Bessemer Group's 13F filing for Q2 2022, filed 10 Aug 2022.